Ergomed

Founded in 1997, Ergomed Group is a dedicated provider of specialized services to the pharmaceutical and biotechnology industries, supporting the development of new drugs. With over 25 years of experience, Ergomed offers custom-made clinical solutions for every stage of development from proof-of-concept to late-stage programs. Operating with a global footprint covering 100+ countries, Ergomed has the capability to deliver solutions for even the toughest clinical development and trial management challenges.

The company's services span all phases of clinical trials and include pharmacovigilance, medical information, and full-range GxP audits. Ergomed’s diverse team, comprising over 1,800 employees operating out of 27 offices worldwide, allows it to cater to a wide array of clients, from top-tier pharmaceutical companies to emerging biotech firms. The combination of specialized expertise in rare diseases and oncology, along with a commitment to quality and innovation, positions Ergomed as a leading partner for drug developers seeking to maximize their regulatory compliance and product value.